Sign in

CIK 0000899923

  • Accelerated filer

MYRIAD GENETICS INC

Sign in to watch
Ticker
MYGN
Exchange
Nasdaq
Industry
In Vitro & In Vivo Diagnostic Substances
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
870494517
Phone
+1 801-584-3600
Business address
322 NORTH 2200 WEST, SALT LAKE CITY, UT, 84116
Former names
MYRIAD GENETICS INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$34,252
in 1 filing

Net −$34,252. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Davis Mark Steven −$34K Director sold 6% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2019-08-01 Capone Mark Christopher President & C.E.O. Exercise or conversion +4,328 $23.11 $100K 445,161
2019-08-01 Capone Mark Christopher President & C.E.O. Sale −4,328 $44.00 $190K 440,833
2019-08-01 Capone Mark Christopher President & C.E.O. Exercise or conversion +58,138 $30.34 $1.8M 498,971
2019-08-01 Capone Mark Christopher President & C.E.O. Sale −58,138 $44.00 $2.6M 440,833
2019-08-01 Capone Mark Christopher President & C.E.O. Exercise or conversion +3,862 $30.34 $117K 444,695
2019-08-01 Capone Mark Christopher President & C.E.O. Sale −3,862 $44.00 $170K 440,833
2019-08-01 Capone Mark Christopher President & C.E.O. Exercise or conversion · Incentive Stock Option (right to buy) −4,328 0
2019-08-01 Capone Mark Christopher President & C.E.O. Exercise or conversion · Incentive Stock Option (right to buy) −3,862 0
2019-08-01 Capone Mark Christopher President & C.E.O. Exercise or conversion · Non-Qualified Stock Option (right to buy) −70,672 0
2019-08-01 Capone Mark Christopher President & C.E.O. Exercise or conversion · Non-Qualified Stock Option (right to buy) −58,138 0
2019-03-12 McDade Ralph L President Myriad RBM, Inc. Sale −1,975 $31.00 $61K 122,604
2019-01-02 Tobin Bernard President Crescendo BioScience Returned to the company −3,734 $29.00 $108K 157,752
2018-11-29 Phanstiel S. Louise Director Grant or award +9,360 40,103
2018-11-29 DREISMANN HEINRICH Director Grant or award +9,360 43,103
2018-11-29 LANGER DENNIS Director Grant or award +9,360 49,103
2018-11-29 GILBERT WALTER PHD Director Grant or award +9,360 36,603
2018-11-29 HENDERSON JOHN T Director Grant or award +9,360 59,103
2018-11-29 BEST LAWRENCE C Director Grant or award +9,360 49,103
2018-10-17 Riggsbee Richard Bryan Chief Financial Officer Returned to the company −3,327 $44.45 $148K 146,966
2018-09-30 Ford Alexander President, MGL Returned to the company −1,830 $46.00 $84K 127,177

Page 37 of 60 · 1,194 trades